Loading…
SIMPATHIC is an EU Horizon Project focused on accelerating drug repurposing for rare neurological, neurometabolic, and neuromuscular disorders by exploiting similarities in clinical and molecular pathology. The project involves 22 international partners and uses patient-derived cells to test existing drugs across multiple rare diseases simultaneously.
AI named SIMPATHIC in March 2026.